Cargando…
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
Autores principales: | Mårtensson, Johan, Bellomo, Rinaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251585/ https://www.ncbi.nlm.nih.gov/pubmed/37291591 http://dx.doi.org/10.1186/s13054-023-04513-7 |
Ejemplares similares
-
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
por: Patoulias, Dimitrios
Publicado: (2023) -
Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?
por: Orive, Gorka, et al.
Publicado: (2020) -
Intention to Treat Analysis: Are We Really Doing It?: Reply
por: Barczyński, Marcin
Publicado: (2013) -
Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study
por: Mårtensson, Johan, et al.
Publicado: (2023) -
So what do we really mean when we say that systems biology is holistic?
por: Gatherer, Derek
Publicado: (2010)